Key result
Carpentier-Edwards bioprosthesis valve replacement had operative mortality of 5.6% (AVR) and 8.7% (MVR), with 10-year freedom from structural deterioration of 89% and 76.4%, respectively.
Cohort (n=191)
Structural valve failure is the most important factor adversely affecting the long-term performance of the Carpentier-Edwards porcine bioprosthesis.
No takes yet. Share an insight, caveat, or question.
These results may inform valve selection for AVR/MVR; extends observational durability data but leaves randomized comparisons open.
Fiane et al. (1997) conducted a cohort in Valvular heart disease requiring valve replacement (n=191). Carpentier-Edwards porcine bioprosthesis was evaluated on Operative mortality. Carpentier-Edwards bioprosthesis valve replacement had operative mortality of 5.6% (AVR) and 8.7% (MVR), with 10-year freedom from structural deterioration of 89% and 76.4%, respectively.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: